TLC-2716
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for TLC-2716, covering 2024-05-20 to 2025-04-03. Get the full timeline:
Most recent: Clinical Trial Update: Phase 2a Study of Safety, Tolerability, and Efficacy of TLC-2716 in Subjects With Hypertriglyceridemia and NAFLD [Phase 2]